Yuanmin N. He

No. 127 Changlexi Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

A two-stage workflow for vitiligo diagnosis: clinical characteristic classification and large language model (LLM)-based report generation.

A two-stage workflow for vitiligo diagnosis: clinical characteristic classification and large language model (LLM)-based report generation.

Journal: Frontiers in immunology

Published: April 11, 2026

Revisiting CCL22 in autoimmune diseases: pathogenesis and clinical implications.

Revisiting CCL22 in autoimmune diseases: pathogenesis and clinical implications.

Journal: International immunopharmacology

Published: January 13, 2026

Case Report: Duodenal neoplasm-induced panniculitis.

Case Report: Duodenal neoplasm-induced panniculitis.

Journal: Frontiers in medicine

Published: December 29, 2025

Lipocalin 2: a double-edged sword in cellular ferroptosis.

Lipocalin 2: a double-edged sword in cellular ferroptosis.

Journal: Cell biology and toxicology

Published: October 17, 2025

A dual-functional mitochondrial probe for melanoma visualization and PI3K/AKT/mTOR-EMT signaling axis-mediated antitumor therapy.

A dual-functional mitochondrial probe for melanoma visualization and PI3K/AKT/mTOR-EMT signaling axis-mediated antitumor therapy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: March 10, 2025

A novel NIR-dependent IDO-inhibiting ethosomes treatment melanoma through PTT/PDT/immunotherapy synergy.

A novel NIR-dependent IDO-inhibiting ethosomes treatment melanoma through PTT/PDT/immunotherapy synergy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: December 26, 2024

IL-7 in autoimmune diseases: mechanisms and therapeutic potential.

IL-7 in autoimmune diseases: mechanisms and therapeutic potential.

Journal: Frontiers in immunology

Published: December 15, 2024

Novel NIR fluorescent probe IR-546 inhibits melanoma through the AKT/GSK3β/β-catenin pathway.

Novel NIR fluorescent probe IR-546 inhibits melanoma through the AKT/GSK3β/β-catenin pathway.

Journal: Molecular medicine (Cambridge, Mass.)

Published: October 10, 2024

Pedunculated Neoplasm of the Vulva.

Pedunculated Neoplasm of the Vulva.

Journal: The American Journal of dermatopathology

Published: June 25, 2024

Gypenosides alleviates HaCaT keratinocyte hyperproliferation and ameliorates imiquimod-induced psoriasis in mice.

Gypenosides alleviates HaCaT keratinocyte hyperproliferation and ameliorates imiquimod-induced psoriasis in mice.

Journal: Allergologia et immunopathologia

Published: June 20, 2024

LL37-DNA Complex Drives Vitiligo Progression Through TLR9-MyD88 Signaling Pathways.

LL37-DNA Complex Drives Vitiligo Progression Through TLR9-MyD88 Signaling Pathways.

Journal: Pigment cell & melanoma research

Published: April 09, 2024

Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.

Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2.

Journal: Molecular therapy oncolytics

Published: November 29, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026